Meeting
2018 ASCO Annual Meeting
Analysis of circulating tumor cells (CTCs) in patients across multiple metastatic breast cancer (mBCa) cohorts identifies marked inter- and intra-patient heterogeneity in CTC size, shape, and overall morphology.
Authors
Gordon Vansant
Epic Sciences, Inc., San Diego, CA
Gordon Vansant , Yipeng Wang , Beverly Hom , Adam Jendrisak , Joseph Schonhoft , Ryon P Graf , Priscilla Ontiveros , Megan Kearney , Mark Andrew Landers , Ryan Dittamore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1084)
DOI
10.1200/JCO.2018.36.15_suppl.1084
Abstract #
1084
Poster Bd #
165
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
The DETECT study concept: Individualized therapy of metastatic breast cancer.
First Author: Arkadius Polasik
Poster
2018 ASCO Annual Meeting
Androgen receptor expression in circulating tumor cells of metastatic breast cancer patients.
First Author: Ingeborg Elisabeth de Kruijff
Poster
2015 ASCO Annual Meeting
The DETECT Study Program: Personalized treatment in advanced breast cancer based on circulating tumor cells (CTCs).
First Author: Amelie Schramm
Poster
2014 ASCO Annual Meeting
DETECT III/IV: Two combined clinical trials based on the phenotype of circulating tumor cells (CTCs).
First Author: Susanne Albrecht